ArticleProstate cancer and prostatic diseases2026

Lipidomic profiling in metastatic prostate cancer captures tumor metabolic rewiring and its modulation by androgen receptor-targeting therapy.

Sara Bleve et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.